FDA Approval | Dominik Mayer – Products, Asia, Productivity

FDA Approval  

In an op-ed for the Los Angeles Times, Dr. Anita Sircar writes about a severely ill COVID patient she treated. The man had not gotten a vaccination. He wanted to wait for full FDA approval to not be “the government’s guinea pig”.

“Well,” I said, “I am going to treat you with remdesivir, which only recently received FDA approval.” I explained that it had been under an EUA for most of last year and had not been studied or administered as widely as COVID-19 vaccines. That more than 353 million doses of COVID-19 vaccine had been administered in the U.S. along with more than 4.7 billion doses worldwide without any overwhelming, catastrophic side effects. “Not nearly as many doses of remdesivir have been given or studied in people and its long-term side effects are still unknown,” I said. “Do you still want me to give it to you?”

Check the article to see how the story continues.